David Slosky
57 works · 3,743 citations · h-index 22
Top works
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- Detection of persistent left superior vena cava by two‐dimensional contrast echocardiography
- Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
- Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
- Rest and exercise hemodynamic effects of oral hydralazine in patients with coronary artery disease and left ventricular dysfunction.
- Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
- Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer
- Diagnosis of Urinary Tract Infection
- Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
- Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis
- Left Atrial Hypertension After Repeated Catheter Ablations for Atrial Fibrillation
- A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
- Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19
- Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator
- Bisphosphonates Inhibit Osteosarcoma-Mediated Osteolysis Via Attenuation of Tumor Expression of MCP-1 and RANKL
- Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
- Pleiotropic effects of bisphosphonates on osteosarcoma
- Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
- Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
- Recognizing and Managing Left Ventricular Dysfunction Associated With Therapeutic Inhibition of the Vascular Endothelial Growth Factor Signaling Pathway